Pacific Edge Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| HOLX | Hologic | Outperform |
8
|
$76.54 | $81.06 | 10.40% | 3 | $17.86B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$42.98 | $0.00 | 16.33% | 3 | $9.39B |
| GH | Guardant Health | Buy |
6
|
$18.88 | $43.00 | 133.05% | 2 | $2.30B |
| NEO | NeoGenomics | Outperform |
8
|
$15.30 | $20.09 | 24.18% | 9 | $1.95B |
| MYGN | Myriad Genetics | Hold |
6
|
$19.47 | $22.08 | 28.40% | 8 | $1.77B |
| VCYT | Veracyte | Outperform |
11
|
$20.35 | $32.17 | 59.71% | 4 | $1.56B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| NSTG | NanoString Technologies | - |
7
|
$0.21 | $5.02 | -100.00% | 4 | $8.52M |